This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1998.
Company Filing History:
1 out of 834,307 Years Active: 1998
Title: Michael E Lombardo: Innovator in Prostatic Cancer Detection
Introduction
Michael E Lombardo is a notable inventor based in Seminole, Florida. He has made significant contributions to the field of medical diagnostics, particularly in the detection of prostatic cancer. His innovative approach has the potential to improve patient outcomes through early detection.
Latest Patents
Lombardo holds a patent for a method designed to detect prostatic cancer. This method involves measuring the pressure of the 5.alpha.-reductase type 2 isozyme in the serum or urine of patients. The technique utilizes a biomarker, specifically polyclonal antibodies of a peptide representing amino acids 28 to 43 of the 5.alpha.-reductase type 2 isozyme. This innovative method aims to provide a more accurate and efficient means of diagnosing prostatic cancer.
Career Highlights
Throughout his career, Lombardo has focused on advancing medical technology and improving diagnostic methods. His work has garnered attention for its potential impact on cancer detection and patient care. With a strong commitment to innovation, he continues to explore new avenues in medical research.
Collaborations
Lombardo has collaborated with notable professionals in his field, including Perry B Hudson and Said I Hakky. These partnerships have contributed to the development and refinement of his patented methods.
Conclusion
Michael E Lombardo's contributions to the field of prostatic cancer detection exemplify the importance of innovation in medical diagnostics. His work not only enhances the understanding of cancer detection but also paves the way for improved patient care.